*NEW* Summer 2008

ESBE becomes the exclusive Canadian distributor for AUTOGENOMICS INC., developers of one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics.